Integrative GWAS and snRNA-seq Reveal a Mesenchymal-Like Endothelial Signature in Moyamoya Disease
Authors:
- Yudai HiranoYHYudai Hirano
- Satoru MiyawakiSMSatoru Miyawaki
- Kyuto SoneharaKSKyuto Sonehara
- Shinichi NambaSNShinichi Namba
- Hirotaka InoueHIHirotaka Inoue
- Yuya ShiraiYSYuya Shirai
- Yumie MizoroYMYumie Mizoro
- the BioBank Japan ProjectTPthe BioBank Japan Project
- 1 May 2026
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1336-1348
Abstract
BACKGROUND: Moyamoya disease (MMD) has a strong genetic basis, with the rare RNF213 p.Arg4810Lys variant (rs112735431) representing a major risk factor, while the broader genetic architecture and disease-relevant vascular cell types remain incompletely understood. METHODS: We conducted a genome-wide association study in Japanese individuals (n=47 656; 401 MMD cases and 47 255 controls). Population-level features at MMD risk loci were examined by regional allele frequency and haplotype analyses. We performed single-nucleus RNA-seq of superficial temporal arteries from patients with MMD (n=3). Cell type–specific enrichment of genome-wide association study signals was assessed using the Single-Cell Disease Relevance Score. Endothelial signatures were validated by integration with publicly available single-cell data sets from controls (n=5) and immunohistochemistry for candidate markers (n=1). RESULTS: Beyond rs112735431, we identified a genome-wide significant signal in the HDAC9-TWIST1 region (rs12530920; P =3.3×10 −14 ; odds ratio, 1.77). Conditional analysis on rs112735431 revealed a protective RNF213 missense variant, p.Asp1331Gly (rs8074015; P =3.7×10 − 9 ; odds ratio, 0.53), whose minor allele was mutually exclusive with rs112735431-A on haplotypes. Population analysis revealed geographic variation and extended haplotype structure of the rs112735431-A allele in Japan. Single-nucleus RNA-seq identified a mesenchymal-like endothelial cell (MEC) population with selective FN1 expression. Genome-wide association study–prioritized disease genes were strongly enriched in MECs. MECs showed mesenchymal pathway activation with a regulatory program distinct from canonical endothelial states. The proportion of MECs was markedly increased in MMD (72% versus 28% in controls), and fibronectin 1 (FN1) expression in endothelial regions was confirmed by immunohistochemistry. CONCLUSIONS: Our findings identify a protective RNF213 p.Asp1331Gly variant (rs8074015) that is mutually exclusive with the known rs112735431-A allele. Genetic risk converges on an MEC state markedly expanded in MMD.Keywords
This publication has 55 references indexed in Scilit:
- A cell and transcriptome atlas of human arterial vasculatureCell Genomics, 2025
- Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicityCell Genomics, 2025
- Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosisCell Reports, 2023
- Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association StudyTranslational Stroke Research, 2022
- Moyamoya disease: diagnosis and interventionsThe Lancet Neurology, 2022
- DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest NeighborsCell Systems, 2019
- Overview of the BioBank Japan Project: Study design and profileJournal of Epidemiology, 2017
- Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseasesJournal of Epidemiology, 2017
- BMP signaling in vascular biology and dysfunctionCytokine & Growth Factor Reviews, 2016
- Moyamoya disease: current concepts and future perspectivesThe Lancet Neurology, 2008